Medical Net, Inc. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

May'25

Feb'25

Nov'24

Aug'24

May'24

Feb'24

Nov'23

Net Sales

1,655.15

1,508.64

1,551.42

1,358.39

1,596.38

1,313.64

1,242.34

Other Operating Income

0.00

Total Operating income

1,655.15

1,508.64

1,551.42

1,358.39

1,596.38

1,313.64

1,242.34

Raw Material Cost

1,155.95

1,034.05

1,021.22

900.61

1,073.67

881.83

738.56

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

2.61

3.02

3.40

2.53

2.56

1.70

0.24

Selling and Distribution Expenses

459.78

450.32

477.16

454.22

453.88

364.70

357.82

Other Expenses

-0.17

0.87

0.08

0.45

0.08

0.14

0.03

Total Expenditure (Excl Depreciation)

1,616.62

1,496.13

1,502.61

1,361.83

1,530.90

1,249.59

1,096.91

Operating Profit (PBDIT) excl Other Income

38.5

12.5

48.8

-3.4000000000000004

65.5

145.39999999999998

Other Income

361.06

13.98

25.18

2.46

10.93

-4.67

6.60

Operating Profit (PBDIT)

418.61

47.57

92.22

17.29

93.52

71.93

164.17

Interest

2.61

3.02

3.40

2.53

2.56

1.70

0.24

Exceptional Items

-322.55

-131.53

-4.39

-3.87

-79.59

-91.22

-4.27

Gross Profit (PBDT)

499.20

474.60

530.21

457.77

522.71

431.81

503.78

Depreciation

19.02

21.09

18.22

18.27

17.11

12.55

12.13

Profit Before Tax

74.43

-108.07

66.22

-7.39

-5.74

-33.54

147.52

Tax

-4.68

10.08

35.29

22.12

29.55

31.22

48.68

Provisions and contingencies

0.00

Profit After Tax

77.14

-128.25

18.45

-35.49

-40.45

-69.36

93.97

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

77.14

-128.25

18.45

-35.49

-40.45

-69.36

93.97

Share in Profit of Associates

0.00

Minority Interest

1.97

10.10

12.47

5.98

5.17

4.60

4.87

Other related items

0.00

Consolidated Net Profit

79.12

-118.15

30.93

-29.52

-35.28

-64.76

98.84

Equity Capital

0.00

Face Value

0.0

Reserves

1,715.81

1,657.49

1,848.94

1,842.66

1,907.22

1,944.15

2,012.15

Earnings per share (EPS)

8.83

-14.28

2.05

-3.92

-4.47

-7.67

10.39

Diluted Earnings per share

8.83

-14.28

2.05

-3.92

-4.47

-7.67

10.39

Operating Profit Margin (Excl OI)

2.33%

0.83%

3.15%

-0.25%

4.1%

4.88%

11.71%

Gross Profit Margin

5.65%

-5.77%

5.44%

0.8%

0.71%

-1.6%

12.85%

PAT Margin

4.66%

-8.5%

1.19%

-2.61%

-2.53%

-5.28%

7.56%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended May 2025 is 6.69%

Consolidate Net Profit

QoQ Growth in quarter ended May 2025 is 155.99%

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended May 2025 is -14.18%

Interest

QoQ Growth in quarter ended May 2025 is -23.53%

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended May 2025 has fallen from Nov 2024

Compare Quarterly Results Of Medical Net, Inc. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(JPY)

Change(%)

Net Sales

1,655.15

1,125.68

529.47

47.04%

Other Operating Income

0.00

Total Operating income

1,655.15

1,125.68

529.47

47.04%

Raw Material Cost

1,155.95

774.92

381.03

49.17%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

2.61

0.71

1.90

267.61%

Selling and Distribution Expenses

459.78

308.29

151.49

49.14%

Other Expenses

-0.17

-0.07

-0.10

-142.86%

Total Expenditure (Excl Depreciation)

1,616.62

1,083.22

533.40

49.24%

Operating Profit (PBDIT) excl Other Income

38.53

42.46

-3.93

-9.26%

Other Income

361.06

-1.24

362.30

29,217.74%

Operating Profit (PBDIT)

418.61

45.07

373.54

828.80%

Interest

2.61

0.71

1.90

267.61%

Exceptional Items

-322.55

0.81

-323.36

-39,920.99%

Gross Profit (PBDT)

499.20

350.75

148.45

42.32%

Depreciation

19.02

3.85

15.17

394.03%

Profit Before Tax

74.43

41.31

33.12

80.17%

Tax

-4.68

0.57

-5.25

-921.05%

Provisions and contingencies

0.00

Profit After Tax

77.14

40.74

36.40

89.35%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

77.14

40.74

36.40

89.35%

Share in Profit of Associates

0.00

Minority Interest

1.97

0.00

1.97

Other related items

0.00

Consolidated Net Profit

79.12

40.74

38.38

94.21%

Equity Capital

0.00

Face Value

0.00

Reserves

1,715.81

620.46

1,095.35

176.54%

Earnings per share (EPS)

8.83

13.09

-4.26

-32.54%

Diluted Earnings per share

8.83

13.09

-4.26

-32.54%

Operating Profit Margin (Excl OI)

2.33%

3.77%

0.00

-1.44%

Gross Profit Margin

5.65%

4.01%

0.00

1.64%

PAT Margin

4.66%

3.62%

0.00

1.04%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 165.52 Million

in May 2025

Figures in Million

QoQ Growth in quarter ended May 2025 is 6.69%

YoY Growth in quarter ended May 2025 is 3.68% vs 16.08% in May 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 7.91 Million

in May 2025

Figures in Million

QoQ Growth in quarter ended May 2025 is 155.99%

YoY Growth in quarter ended May 2025 is 324.08% vs 19.95% in May 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 5.75 Million

in May 2025

Figures in Million

QoQ Growth in quarter ended May 2025 is -14.18%

YoY Growth in quarter ended May 2025 is -30.39% vs -38.86% in May 2024

Quarterly - Interest

Interest 0.26 Million

in May 2025

Figures in Million

QoQ Growth in quarter ended May 2025 is -23.53%

YoY Growth in quarter ended May 2025 is 0.00% vs 0.00% in May 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 2.33%

in May 2025

Figures in %

QoQ Growth in quarter ended May 2025 has fallen from Nov 2024

YoY Growth in quarter ended May 2025 has fallen from May 2024